The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC).
 
Jonathan Spicer
No Relationships to Disclose
 
Changli Wang
No Relationships to Disclose
 
Fumihiro Tanaka
No Relationships to Disclose
 
Gene Brian Saylors
No Relationships to Disclose
 
Ke-Neng Chen
No Relationships to Disclose
 
Moishe Liberman
No Relationships to Disclose
 
Everett E. Vokes
No Relationships to Disclose
 
Nicolas Girard
No Relationships to Disclose
 
Shun Lu
No Relationships to Disclose
 
Mariano Provencio
No Relationships to Disclose
 
Tetsuya Mitsudomi
No Relationships to Disclose
 
Mark M. Awad
No Relationships to Disclose
 
Enriqueta Felip
No Relationships to Disclose
 
Patrick M. Forde
No Relationships to Disclose
 
Scott Swanson
No Relationships to Disclose
 
Julie R. Brahmer
No Relationships to Disclose
 
Keith Kerr
No Relationships to Disclose
 
Cécile Dorange
No Relationships to Disclose
 
Junliang Cai
No Relationships to Disclose
 
Stephen Broderick
No Relationships to Disclose